Some examples of targeted therapies include PDE5 inhibitor chemotherapy or checkpoint inhibitors, such as PD-1/PD-L1 inhibitors, which could increase the effectiveness of treatment by targeting two types of tumor cells and the TME (Hao et al., 2023[49]). The gene discussed is PDE5A; the disease is neoplasm.